ConductScience.org, home

Paper16612464

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug.

Zuardi AW and 4 others. Braz J Med Biol Res, 2006. Cited by 273 papers, by iCite.

Cite this record

ConductScience Library. Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug. Papers, record 16612464. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16612464

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug.
PubMed
Journal
Braz J Med Biol Res
PubMed
Year
2006
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
273
iCite
Relative citation ratio, by iCite
8.6
iCite
Revised in PubMed
2022-03-21
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zuardi AWA W
2Crippa JAJ A S
3Hallak JEJ E C
4Moreira FAF A
5Guimarães FSF S

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Anxiety AgentsMajor topic
Antipsychotic AgentsMajor topic
CannabidiolMajor topic
CannabisMajor topic
SchizophreniaMajor topic
Animals
Clinical Trials as Topic
Disease Models, Animal
Humans
Mental Disorders
Mice
Rats

Source PubMed

Download CSV of topics

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT04406948Study of Safety and Efficacy of MGCND00EP1 as an Add on Treatment in Children and Adolescents With Resistant EpilepsiesBackgroundClinicalTrials.gov
NCT06218056Cannabidiol for Reducing Cigarette UseBackgroundClinicalTrials.gov

Download CSV of trials

Cited by120

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 273 citations.

PMIDTitleJournalYearIn PapersSource
42622700Low-Dose Cannabidiol Treatment does not Alter Cognitive Performance in the HIV-1 Transgenic Rat Model of NeuroHIV.J Neuroimmune Pharmacol2026https://conductscience.org/library/papers/42622700PubMed
42404720Phytomedicines in preclinical and clinical research on antipsychotics-induced EPS/EPS-like behaviors: therapeutic effects and neurobiological mechanisms.Front Psychiatry2026https://conductscience.org/library/papers/42404720PubMed
42047775Cannabidiol for the treatment of positive and negative symptoms in schizophrenia spectrum disorders: a systematic review and meta-analysis.Eur Arch Psychiatry Clin Neurosci2026https://conductscience.org/library/papers/42047775PubMed
41369966Unraveling Cannabidiol's Dual Modulatory Role in Schizophrenia: Network Pharmacology and In Vivo Validation of Neuroinflammatory and Behavioral Modulation.Mol Neurobiol2025https://conductscience.org/library/papers/41369966PubMed
40864738Molecular Crosstalk and Therapeutic Synergy: Tyrosine Kinase Inhibitors and Cannabidiol in Oral Cancer Treatment.Curr Issues Mol Biol2025https://conductscience.org/library/papers/40864738PubMed
40163146
Early oral administration of THC:CBD formulations prevent pain-related behaviors without exacerbating paclitaxel-induced changes in weight, locomotion, and anxiety in a rat model of chemotherapy-induced neuropathy.
Psychopharmacology (Berl)2025https://conductscience.org/library/papers/40163146PubMed
40032878A long road ahead to reliable and complete medicinal plant genomes.Nat Commun2025https://conductscience.org/library/papers/40032878PubMed
39987154Evaluation of cannabidiol-based products in Brazil: how can current regulations influence their labeling quality?J Cannabis Res2025https://conductscience.org/library/papers/39987154PubMed
38849155The Development of Cannabinoids as Therapeutic Agents in the United States.Pharmacol Rev2024https://conductscience.org/library/papers/38849155PubMed
38482521How Precise are Nanomedicines in Overcoming the Blood-Brain Barrier? A Comprehensive Review of the Literature.Int J Nanomedicine2024https://conductscience.org/library/papers/38482521PubMed
38418942Characterization of indigenous populations of cannabis in Iran: a morphological and phenological study.BMC Plant Biol2024https://conductscience.org/library/papers/38418942PubMed
38196922Does cannabis affect cognitive functioning in patients with schizophrenia?Schizophr Res Cogn2024https://conductscience.org/library/papers/38196922PubMed
37692969Effects of sub-chronic nabiximols on biological markers of individuals undergoing a clinical trial for the treatment of cannabis use disorder.Am J Transl Res2023https://conductscience.org/library/papers/37692969PubMed
37132109Phytocannabinoids as Potential Multitargeting Neuroprotectants in Alzheimer's Disease.Curr Drug Res Rev2024https://conductscience.org/library/papers/37132109PubMed
37009000Crosstalk between the endocannabinoid and mid-brain dopaminergic systems: Implication in dopamine dysregulation.Front Behav Neurosci2023https://conductscience.org/library/papers/37009000PubMed
36946485Update on Cannabidiol Clinical Toxicity and Adverse Effects: A Systematic Review.Curr Neuropharmacol2023https://conductscience.org/library/papers/36946485PubMed
36671547Effect of Cannabis on Memory Consolidation, Learning and Retrieval and Its Current Legal Status in India: A Review.Biomolecules2023https://conductscience.org/library/papers/36671547PubMed
36636553How do phytocannabinoids affect cardiovascular health? An update on the most common cardiovascular diseases.Ther Adv Chronic Dis2023https://conductscience.org/library/papers/36636553PubMed
36555480Real-Time Monitoring of the Cytotoxic and Antimetastatic Properties of Cannabidiol in Human Oral Squamous Cell Carcinoma Cells Using Electric Cell-Substrate Impedance Sensing.Int J Mol Sci2022https://conductscience.org/library/papers/36555480PubMed
35327432Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles.Biomedicines2022https://conductscience.org/library/papers/35327432PubMed

See all 120 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16612464

GET https://conductscience.org/api/papers/v1/16612464/cited_by?page=2